HIV/AIDS Update - Kaletra (lopinavir/ritonavir) label update: drug interaction information

On January 17, 2013, FDA approved revisions to the Kaletra (lopinavir/ritonavir) labels to include new drug interaction information. The following updates were included. Anticoagulants: Rivaroxaban. Avoid concomitant use of rivaroxaban and Kaletra....
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news